Technetium-99m sestamibi leg scintigraphy for non-invasive assessment of propionyl-L-carnitine induced changes in skeletal muscle metabolism.

Cittanti, C; Colamussi, P; Giganti, M; Orlandi, C; Uccelli, L; Manfrini, S; Azzena, G; Piffanelli, A

Cittanti, C; Colamussi, P; Giganti, M; Orlandi, C; Uccelli, L; Manfrini, S; Azzena, G; Piffanelli, A.

Affiliation

Cittanti C; Department of Nuclear Medicine, University of Ferrara, Italy.

Eur J Nucl Med ; 24(7): 762-6, 1997 Jul.

Article in En | MEDLINE | ID: mdl-9211762

Subject(s)

Arterial Occlusive Diseases/diagnostic imaging; Arterial Occlusive Diseases/drug therapy; Carnitine/analogs & derivatives; Muscle, Skeletal/diagnostic imaging; Peripheral Vascular Diseases/diagnostic imaging; Peripheral Vascular Diseases/drug therapy; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Carnitine/therapeutic use; Female; Humans; Leg/blood supply; Leg/diagnostic imaging; Male; Middle Aged; Muscle, Skeletal/drug effects; Muscle, Skeletal/metabolism; Radionuclide Imaging; Ultrasonography, Doppler

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Arterial Occlusive Diseases / Carnitine / Peripheral Vascular Diseases / Technetium Tc 99m Sestamibi / Muscle, Skeletal / Radiopharmaceuticals Type of study: Clinical_trials / Guideline Limits: Female / Humans / Male / Middle aged Language: En Journal: Eur J Nucl Med Year: 1997 Type: Article Affiliation country: Italy

Search on Google

XML

PubMed Links